Chart: The Device Center Matrix
This article was originally published in The Gray Sheet
Executive Summary
CDRH plans to launch 13 matrix networks in January to help the center make better use of postmarket safety information. The groups, broken down by product categories and some crosscutting issues, will be staffed by experts from each of CDRH's offices and will have liaisons to keep in close contact with each office as represented below.
You may also be interested in...
CDRH Unveils Its Collaborative Matrix Organization To Help Safety Reviews
FDA's device center has identified 13 collaborative product groups - or "matrix groups" - that will begin functioning in January to enhance its ability to make use of postmarket safety information
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.